AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Rapid Local Ischemic Postconditioning on Stroke After Thrombectomy

RecruitingNAAges 18 Years - 85 YearsAllShanghai Jiao Tong University Affiliated Sixth Peโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The main goal of this study is to find out if a new, quick "brain rescue" procedure can help people recover better from a severe stroke caused by a large vessel occlusion. When someone has this type of stroke, doctors often perform a procedure called an endovascular thrombectomy (EVT). In EVT, they thread a thin tube through a blood vessel up to the brain to remove the clot and restore blood flow. This is a highly effective treatment. However, for some patients, suddenly restoring blood flow can cause additional, unexpected injury to the brain. This is called "reperfusion injury." This study tests a technique called rapid local ischemic postconditioning (RL-IPostC) that might prevent this extra damage. It's a very simple additional step performed immediately after the clot is successfully removed. The doctor would briefly inflate and deflate a tiny balloon inside the proximal brain ar

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age 18-85 years 2. Diagnosis of acute ischemic stroke 3. Pre-stroke mRS 0-1 4. Baseline NIHSS score โ‰ฅ 6 5. Time from symptom onset to start of endovascular procedure (puncture) \< 24 hours; onset time defined as "last known well" time 6. Imaging criteria: ASPECTS 3-5 on CT, or ASPECTS \> 5 with acute ischemic core volume (defined as rCBF \< 30% or ADC \< 620) โ‰ฅ 50 mL 7. Occlusion of the intracranial segment of the internal carotid artery or the middle cerebral artery (M1/M2), confirmed as the symptomatic culprit vessel 8. After thrombectomy, the culprit vessel is considered to be occluded by an embolus, and successful recanalization (mTICI 2b/3, i.e., โ‰ฅ 50% perfusion) is achieved 9. Written informed consent signed by the patient or a legal representative Exclusion Criteria: 1. Presence of stenosis (โ‰ฅ 50%) in the ipsilateral middle cerebral artery, internal carotid artery, or common carotid artery proximal to the occlusion site 2. Multiple emboli across different circulations (simultaneous anterior and posterior circulation emboli, or simultaneous left and right anterior circulation emboli) 3. Evidence on CT of extensive cerebral edema, midline shift, significant mass effect, or signs of brain herniation 4. Presence of a life-threatening disease with a prognosis \< 6 months, making 3-month follow-up impossible 5. Severe psychiatric disorder or heart failure 6. Concurrent participation in another clinical drug or device study 7. Any other condition that, in the investigator's judgment, makes the subject unsuitable for this study
๐Ÿ’Š

What it tests

  • High-dose RL-IPostC
  • Low-dose RL-IPostC
๐Ÿ“

Where

1 site
Jiangshan Deng
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy